CONTEXT: Continuing the theme of under-representation in clinical trials that develop new treatments, especially in oncology, this article reports on the discussion at the European Hematology Association (EHA) 2021 Virtual Continue Reading
CONTEXT: Further evidence of ancestry-based disparities in cancer treatment from this study, believed to be the largest of it’s type so far. The analysis of data from over 11,000 men Continue Reading
CONTEXT: Report of new data to be presented by Abbvie at the European Hematology Association (EHA) Virtual Congress derived from the informCLLTM registry assessing how real-word treatment patterns align with Continue Reading
CONTEXT: We’ve covered reports around this theme before, so good to see further research supporting why it is important to have representative ethnic diversity in all studies on new therapies, Continue Reading
CONTEXT: Report from ASCO 2021 from the MYLUNG Consortium research study in metastatic NSCLC. The findings based on the results from the first of 5 protocols is a retrospective review Continue Reading
CONTEXT: Report of one poster presentation and four abstracts derived from Synapse’ RWD capabilities at ASCO 2021. Further evidence of RWD becoming an increasingly valuable tool for oncology research. IMPACT: Continue Reading
CONTEXT: Report of two abstracts presented by Lucence at ASCO 2021 detailing their molecular profiling of advanced cancers in a real-world setting using a liquid biopsy assay and results of Continue Reading
CONTEXT: Transcript of a poster presentation made at the National Comprehensive Cancer Network (NCCN) Annual Conference 2021 on real-world outcomes of febrile neutropenia among patients with breast cancer or non-hodgkin Continue Reading
CONTEXT: A philanthropy-fuelled database created at the University of Calgary is proving its value and attracting international attention, including for some highly encouraging new research for treating lung cancer (NSCLC) | Cananda only data Continue Reading
CONTEXT: Report of a paper published in Immunotherapy, May 26th 2021 edition describing RWE study of PD-L1 testing patterns and treatment distribution in patients with NSCLC in Israel. The results Continue Reading
